Literature DB >> 24247629

High grade transformation in a case of adenoid cystic carcinoma associated with Epstein-Barr virus expression.

Chanh K Ly1, Hui M Cheng, Tersia Vermeulen.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24247629     DOI： 10.1097/PAT.0000000000000012

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  4 in total

1.  Salivary gland hybrid tumour revisited: could they represent high-grade transformation in a low-grade neoplasm?

Authors:  Henrik Hellquist; Alena Skalova; Bahram Azadeh
Journal:  Virchows Arch       Date:  2016-09-07       Impact factor: 4.064

2.  Adenoid Cystic Carcinoma with Transformation to High Grade Carcinomatous and Sarcomatoid Components: A Rare Case Report with Review of Literature.

Authors:  Anupurva Dutta; Pattatheyil Arun; Indu Arun
Journal:  Head Neck Pathol       Date:  2020-01-02

Review 3.  Cervical Lymph Node Metastasis in High-Grade Transformation of Head and Neck Adenoid Cystic Carcinoma: A Collective International Review.

Authors:  Henrik Hellquist; Alena Skálová; Leon Barnes; Antonio Cardesa; Lester D R Thompson; Asterios Triantafyllou; Michelle D Williams; Kenneth O Devaney; Douglas R Gnepp; Justin A Bishop; Bruce M Wenig; Carlos Suárez; Juan P Rodrigo; Andrés Coca-Pelaz; Primož Strojan; Jatin P Shah; Marc Hamoir; Patrick J Bradley; Carl E Silver; Pieter J Slootweg; Vincent Vander Poorten; Afshin Teymoortash; Jesus E Medina; K Thomas Robbins; Karen T Pitman; Luiz P Kowalski; Remco de Bree; William M Mendenhall; Jean Anderson Eloy; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2016-02-19       Impact factor: 3.845

4.  Exploration of High-Grade Transformation and Postoperative Radiotherapy on Prognostic Analysis for Primary Adenoid Cystic Carcinoma of the Head and Neck.

Authors:  Yuelu Zhu; Xinyi Zhu; Xuemin Xue; Ye Zhang; Chunfang Hu; Wenchao Liu; Haizhen Lu
Journal:  Front Oncol       Date:  2021-04-09       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.